DrugBank won't provide nor purchase medications. Pricing information and facts is equipped for informational uses only.Genentech requested a Listening to, which was granted in June 2011. The FDA dominated to withdraw the breast cancer sign in November 2011. FDA acceptance is required for Genentech to current market a drug for that indication. Physi… Read More

Lusutrombopag (Mulpleta®), an orally bioavailable, smaller molecule thrombopoietin receptor agonist, is permitted for the treatment of thrombocytopenia in Grownup clients with chronic liver condition who're scheduled to endure a method. In placebo-controlled phase three medical trials, lusutrombopag noticeably greater the proportion of people who… Read More